Fluoroquinolone psychiatric adverse effects: review of cases from the french pharmacovigilance database;Effets indésirables psychiatriques des fluoroquinolones : cas notifiés à la pharmacovigilance française

Revue de Medecine Interne

Volumn 27, Issue 6, 2006, Pages 448-452

  Doussau de Bazignan, A ^a   Thiessard, F ^b   Miremont Salame G ^a   Conri, C ^a   Haramburu, F ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

Author keywords

Adverse effects; Fluoroquinolones; Psychiatry

Indexed keywords

ATROPINE; CIPROFLOXACIN; DILTIAZEM; ENOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ADOLESCENT; ADULT; AGED; AGING; AGITATION; AMNESIA; ANXIETY; ARTICLE; CONFUSION; DATA ANALYSIS; DATA BASE; DELIRIUM; DELUSION; DEMOGRAPHY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DOSE CALCULATION; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; FEMALE; GROUPS BY AGE; HALLUCINATION; HOSPITALIZATION; HUMAN; INSOMNIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PERSONALITY DISORDER; PHASEOLUS VULGARIS; SCHOOL CHILD; SEX DIFFERENCE; SIDE EFFECT; SOMNOLENCE;

EID: 33744517107     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.02.003     Document Type: Article

References (10)

1. Leone R., Venegoni M., Motola D., Moretti U., Piazzetta V., Cocci A., et al. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions. Drug Saf. 26 (2003) 109-120
2. Fish D.N. Fluoroquinolone adverse effects and drug interactions. Pharmacotherapy 21 (2001) 253S-272S
3. Hooper D.C., and Wolfson J.S. Fluoroquinolone antimicrobial agents. N. Engl. J. Med. 324 (1991) 384-394
4. Blum M.D., Graham D.J., and McCloskey C.A. Temafloxacin syndrome: review of 95 cases. Clin. Infect. Dis. 18 (1994) 946-950
5. ICH harmonised tripartite guideline E2D. Post-approval safety data management: definitions and standards for expedited reporting 2003.
6. Moride Y., Haramburu F., Alvarez Requejo A., and Bégaud B. Under-reporting of adverse drug reaction in general practice. Br. J. Clin. Pharmacol. 43 (1997) 177-181
7. Alvarez-Requejo A., Carvajal A., Begaud B., Moride Y., Vega T., and Arias L.H. Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur. J. Clin. Pharmacol. 54 (1998) 483-488
8. Royer R.J. Adverse drug reactions with fluoroquinolones. Therapie 51 (1996) 414-416
9. Ball P., and Tillotson G. Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug Saf. 13 (1995) 343-358
10. De Sarro A., and De Sarro G. Adverse reactions to fluoroquinolones. An overview on mechanistic aspects. Curr. Med. Chem. 8 (2001) 371-384